Sakar Healthcare Share Price
Sakar Healthcare Share Price Today
As of 5 Jul 2026, Sakar Healthcare share price is ₹848.80. The stock opened at ₹851.40, compared to its previous close of ₹834.20. During today's trading session, Sakar Healthcare share price moved in the range of ₹830.90 to ₹879.20, with an average price of ₹855.05 for the day. Looking at its last 52-week, the stock has touched a low of ₹311.00 and a high of ₹889.95. On the performance front, Sakar Healthcare share price has increased by 108.78% over the last six months and is up 144.51% on a year-on-year basis.
Sakar Healthcare Returns Calculator
Sakar Healthcare Shareholder Returns
Sakar Healthcare Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
Sakar Healthcare Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹177.58 | ₹153.35 | ₹133.36 | ₹128.23 |
| Other Income | ₹1.31 | ₹3.18 | ₹4.67 | ₹2.17 |
| Total Revenue | ₹178.90 | ₹156.53 | ₹138.03 | ₹130.40 |
| Total Expenses | ₹157.32 | ₹140.63 | ₹121.15 | ₹111.39 |
| Profit Before Tax | ₹21.53 | ₹15.90 | ₹16.88 | ₹19.01 |
| Tax | ₹4.03 | ₹4.23 | ₹4.12 | ₹3.77 |
| Profit After Tax | ₹17.50 | ₹11.67 | ₹12.76 | ₹15.24 |
| EPS - Basic | ₹7.97 | ₹5.64 | ₹6.75 | ₹9.96 |
| EPS - Diluted | ₹7.95 | ₹5.63 | ₹6.75 | ₹9.96 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹21.53 | ₹15.90 | ₹16.88 | ₹19.01 |
| Income before WC changes | ₹50.49 | ₹40.80 | ₹37.01 | ₹31.43 |
| Change in Assets | -₹17.29 | -₹18.76 | -₹9.01 | -₹9.25 |
| Change in Liabilities | ₹3.21 | ₹5.57 | ₹9.60 | ₹13.34 |
| Change in WC | -₹14.08 | -₹13.18 | ₹0.60 | ₹4.09 |
| Cash flow from Operations | ₹34.03 | ₹24.47 | ₹33.34 | ₹35.70 |
| Cash flow from Investing | -₹30.71 | -₹51.54 | -₹74.38 | -₹90.37 |
| Cash flow from Financing | -₹3.48 | ₹27.44 | ₹41.10 | ₹54.62 |
| Total Cash Flow | -₹0.16 | ₹0.37 | ₹0.06 | -₹0.05 |
| Cash (Start of the year) | ₹0.47 | ₹0.09 | ₹0.03 | ₹0.08 |
| Cash (End of the year) | ₹0.31 | ₹0.47 | ₹0.09 | ₹0.03 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹326.53 | ₹317.05 | ₹280.42 | ₹217.74 |
| Current Assets | ₹88.73 | ₹71.61 | ₹55.92 | ₹50.02 |
| Total Assets | ₹415.26 | ₹388.66 | ₹336.34 | ₹267.76 |
| Current Liabilities | ₹63.19 | ₹59.06 | ₹54.49 | ₹46.78 |
| Net Current Asset | ₹25.54 | ₹12.55 | ₹1.42 | ₹3.25 |
| Non-Current Liabilities | ₹66.60 | ₹67.27 | ₹108.50 | ₹93.54 |
| Equity Capital | ₹285.48 | ₹262.33 | ₹173.35 | ₹127.45 |
| Total Equity & Liabilities | ₹415.26 | ₹388.66 | ₹336.34 | ₹267.76 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹177.58 | ₹153.35 | ₹133.36 | ₹128.23 |
| Other Income | ₹1.31 | ₹3.18 | ₹4.67 | ₹2.17 |
| Total Revenue | ₹178.90 | ₹156.53 | ₹138.03 | ₹130.40 |
| Total Expenses | ₹157.32 | ₹140.63 | ₹121.15 | ₹111.39 |
| Profit Before Tax | ₹21.53 | ₹15.90 | ₹16.88 | ₹19.01 |
| Tax | ₹4.03 | ₹4.23 | ₹4.12 | ₹3.77 |
| Profit After Tax | ₹17.50 | ₹11.67 | ₹12.76 | ₹15.24 |
| EPS - Basic | ₹7.97 | ₹5.64 | ₹6.75 | ₹9.96 |
| EPS - Diluted | ₹7.95 | ₹5.63 | ₹6.75 | ₹9.96 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹21.53 | ₹15.90 | ₹16.88 | ₹19.01 |
| Income before WC changes | ₹50.49 | ₹40.80 | ₹37.01 | ₹31.51 |
| Change in Assets | -₹17.29 | -₹18.76 | -₹9.01 | -₹9.25 |
| Change in Liabilities | ₹3.21 | ₹5.57 | ₹9.60 | ₹13.34 |
| Change in WC | -₹14.08 | -₹13.18 | ₹0.60 | ₹4.09 |
| Cash flow from Operations | ₹34.03 | ₹24.47 | ₹33.34 | ₹35.79 |
| Cash flow from Investing | -₹30.71 | -₹51.54 | -₹74.38 | -₹90.40 |
| Cash flow from Financing | -₹3.48 | ₹27.44 | ₹41.10 | ₹54.56 |
| Total Cash Flow | -₹0.16 | ₹0.37 | ₹0.06 | -₹0.05 |
| Cash (Start of the year) | ₹0.46 | ₹0.09 | ₹0.03 | ₹0.08 |
| Cash (End of the year) | ₹0.31 | ₹0.46 | ₹0.09 | ₹0.03 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹326.54 | ₹317.06 | ₹280.43 | ₹217.75 |
| Current Assets | ₹88.80 | ₹71.69 | ₹55.99 | ₹50.10 |
| Total Assets | ₹415.35 | ₹388.74 | ₹336.42 | ₹267.85 |
| Current Liabilities | ₹63.19 | ₹59.06 | ₹54.49 | ₹46.78 |
| Net Current Asset | ₹25.62 | ₹12.63 | ₹1.50 | ₹3.32 |
| Non-Current Liabilities | ₹66.60 | ₹67.27 | ₹108.50 | ₹93.54 |
| Equity Capital | ₹285.56 | ₹262.42 | ₹173.43 | ₹127.54 |
| Total Equity & Liabilities | ₹415.35 | ₹388.74 | ₹336.42 | ₹267.85 |
About Sakar Healthcare
Sakar Healthcare Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing of pharmaceutical products providing liquid orals, cephalosporin tablets, capsules, dry powder syrup, dry powder injections, liquid injectables (SVP) in ampoules and vials & lyophilized injections. The Company's oncology products include oral solid dosage (tablet & capsule), liquid injection, lyophilized injection, active pharmaceutical ingredient (API), CDMO products and CRAMs. It has a presence across the regions of Africa (Anglo & Francophone), SEASIA, CIS, Latin & Central America and in Europe. It operates in over 50 countries globally and has approximately 292 registered products. It exports to Southeast Asia, Asia, Africa-Anglo & Francophone, MENA, America, covering around 38 countries with more than 250 brands registered.
Sakar Healthcare Financial Highlights
- Revenue: Sakar Healthcare reported revenue of ₹254.03 crore in FY26 vs ₹178.89 crore in FY25. It showed an increase of 42.00% on a yearly basis.
- Operating Profit: Sakar Healthcare reported an operating profit of ₹39.76 crore in FY26 vs ₹21.53 crore in FY25. It showed an increase of 84.67% on a year-on-year basis.
- Net Profit: Sakar Healthcare reported a net profit of ₹30.48 crore in FY26 vs ₹17.50 crore in FY25. It showed an increase of 74.17% on a yearly basis.
Sakar Healthcare Quarterly Result Highlights
- Sakar Healthcare reported revenue of ₹71.27 crore in Mar 2026, compared with ₹70.85 crore in Dec 2025, representing an increase of 0.59% on a quarter-on-quarter (QoQ) basis.
- Sakar Healthcare reported an operating profit of ₹18.06 crore in Mar 2026, compared with ₹10.95 crore in Dec 2025, representing an increase of 64.93% on a quarter-on-quarter (QoQ) basis.
- Sakar Healthcare reported a profit of ₹11.02 crore in Mar 2026, compared with ₹10.25 crore in Dec 2025, reflecting an increase of 7.51% on a QoQ basis.
- The earnings per share (EPS) of Sakar Healthcare stood at ₹7.97 during Mar 2026.
Similar Stocks
FAQs on Sakar Healthcare Share Price
What is Sakar Healthcare share price today?
Sakar Healthcare share price is ₹848.80 as on 03 Jul, 2026, 15:56 IST.
How has the Sakar Healthcare share price performed in the past?
In the last 1 year, Sakar Healthcare delivered a return of 144.51%. The Sakar Healthcare share price hit a high of ₹889.95 and low of ₹311.00.
How much is the Mutual Fund shareholding in Sakar Healthcare shares?
The Mutual Fund Shareholding in Sakar Healthcare was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of Sakar Healthcare shares ?
The 52-week high and low of Sakar Healthcare share is ₹889.95 and ₹311.00 as of 03 Jul, 2026.
What is the market cap of Sakar Healthcare?
The market capitalisation of Sakar Healthcare is ₹1,856.09 Crores as on 03 Jul, 2026.
What are the stock symbols of Sakar Healthcare?
The stock symbol of Sakar Healthcare is SAKAR on the NSE, , and the ISIN is INE732S01012.
What was yesterday's closing price for Sakar Healthcare shares ?
Sakar Healthcare shares closed yesterday at ₹834.20 on NSE
How to buy Sakar Healthcare shares?
To buy Sakar Healthcare shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Sakar Healthcare shares on Holidays?
No, shares of Sakar Healthcare or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Sakar Healthcare shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Sakar Healthcare?
The PE and PB ratio of Sakar Healthcare is 60.89 and 5.72 respectively, as on 03 Jul, 2026, 15:56 IST.